Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New High

Biotech stocks were broadly higher after several company-specific catalysts: Attovia Therapeutics surged on its Nasdaq debut, American Well moved higher after reporting a narrower loss, Perrigo swung back to profit, and UroGen Pharma rallied following strong Q2 results. Overall read-through is positive skew toward improving profitability and early market traction for recent entrants.

Analysis

Biotech stocks were broadly higher after several company-specific catalysts: Attovia Therapeutics surged on its Nasdaq debut, American Well moved higher after reporting a narrower loss, Perrigo swung back to profit, and UroGen Pharma rallied following strong Q2 results. Overall read-through is positive skew toward improving profitability and early market traction for recent entrants.